3,4-dihydroxyphenylethanol has been researched along with Kahler Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amodio, N; Citraro, R; De Sarro, G; Gallo Cantafio, ME; Juli, G; Neri, A; Oliverio, M; Procopio, A; Rocca, C; Tassone, P; Todoerti, K; Viglietto, G | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylethanol and Kahler Disease
| Article | Year |
|---|---|
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Multiple Myeloma; Phenylethyl Alcohol; Plasma Cells; Signal Transduction | 2021 |